Tag Archives: Warren Woessner

Takeaways from Chisum Patent Academy 2015 Seminar in Cincinnati

Posted on March 11, 2015 by Warren Woessner

Guest Post from Don Chisum On March 5-6, 2015 the Chisum Patent Academy held a two-day seminar at the 21C Museum Hotel in downtown Cincinnati, Ohio to discuss and debate current developments in U.S. patent law. The roundtable seminar group … Continue reading →

Posted in Conferences and Classes, Uncategorized | Tagged , , , , , , , | Leave a comment

Novartis Wins Landmark Biosimilar Approval

Posted on March 9, 2015 by Warren Woessner

Novartis Navigates The FDA-ACA Maze – Gets Approval For Generic Neuprogen. Amgen will soon find itself in a price war with Sandoz – a Novartis company – as it tries to maintain its share of the market for Neuprogen (filgraslim). … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , | Leave a comment

Pacing Technologies v. Garmin – D&D Explained

Posted on February 20, 2015 by Warren Woessner

In this decision—No. 2014-1396 (Fed. Cir., Feb. 18, 2015)—the court affirmed a grant of summary judgment (a copy can be found at the end of this post) that Garmin’s exercise products do not infringe the claims of Pacing’s US Pat. … Continue reading →

Posted in Claim Interpretation, Patent Eligible Subject Matter | Tagged , , , , | Leave a comment

“Precision Medicine” Initiative Leaves Patents “Lost in Space”

Posted on February 18, 2015 by Warren Woessner

On January 30th, the White House released a press release expanding upon President Obama’s mention of “precision medicine” in his State of the Union Address. Not surprisingly, the details are pretty much what we who are involved in various aspects … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , | Leave a comment